Room 1, 4F, Convention Center
Nephrology Board Review Course 1  KOR

May 17(Thu), 13:00-15:20

Chair(s)Beom Seok Kim (Korea)
[BRC-01] Functional alterations of the kidney and urinary tract in the elderly Kook-Hwan Oh (Korea)
[BRC-02] Functional evaluation of the kidney and urinary tract in the elderly Seung Hyeok Han (Korea)
[BRC-03] Pathophysiology and clinical meaning of CKD in the elderlyBum Soon Choi (Korea)
[BRC-04] Medication issues in the elderly–drug selection, dosing, drug interactionSang Ho Lee (Korea)
Room 1, 4F, Convention Center
Nephrology Board Review Course 2  KOR

May 17(Thu), 15:20-17:00

Chair(s)Sang-Youb Han (Korea)
[BRC-05] Assessment, diagnosis and treatment of AKI in the elderlyHye Ryoun Jang (Korea)
[BRC-06] Renal replacement therapy in the elderly Dong-Ryeol Ryu (Korea)
[BRC-07] Fluid therapy in the elderly Sejoong Kim (Korea)
Room 2, 4F, Convention Center
Acute Kidney Injury  KOR

May 17(Thu), 13:00-15:00

Chair(s)Won Yong Cho (Korea), Dong Won Lee (Korea)
[AKI 01-01] Normotensive ischemic AKI Hye Ryoun Jang (Korea)
[AKI 01-02] Acute kidney injury in the transplant patient Sik Lee (Korea)
[AKI 01-03] The distant organ effects of acute kidney injury Hyo-Wook Gil (Korea)
[AKI 01-04] AKI outcomes : CKD and others Dong-Jin Oh (Korea)
Room 3, 4F, Convention Center
Hypertension and Vascular Biology  KOR

May 17(Thu), 13:00-15:00

Chair(s)JongUn Lee (Korea), Sung Kwang Park (Korea)
[HTN-01] Salt, diseased kidney, and hypertension Gheun-Ho Kim (Korea)
[HTN-02] RAAS in hypertension and kidney disease Eun Hui Bae (Korea)
[HTN-03] Evidence for treatment of uncomplicated, stage 1 hypertension: what is the evidence? Chan Joo Lee (Korea)
[HTN-04] Target of diastolic blood pressure and pulse pressure in CKD patients Dong-Ryeol Ryu (Korea)
Room 4, 3F, Convention Center
Kidney Academy  KOR

May 17(Thu), 13:00-15:00

Chair(s)Seok Joon Shin (Korea)
[KA-01] Update on management of CKD-MBDShin Young Ahn (Korea)
[KA-02] Clinical implication and management of hyperkalemiaEunsil Koh (Korea)
[KA-03] Anemia management in CKD: based on the latest knowledge of iron and ESA treatmentHyo Jin Kim (Korea)
[KA-04] Plain, aging in healthyHo Seok Koo (Korea)
Room 2, 4F, Convention Center
Oral Communications (Dialysis 1)  KOR

May 17(Thu), 15:00-17:00

Chair(s)Young Ok Kim (Korea), Jun Young Do (Korea)
[OR 01 DL-01] The association of serum mineral parameters with mortality in hemodialysis patients: Data analysis from Korean end-stage renal disease registry Yunmi Kim (Korea)
[OR 01 DL-02] Current Status of Clinical Practice for Hemodialysis Vascular Access in Korea: Observational study based on Korean Health Insurance Database Hyung Seok Lee (Korea)
[OR 01 DL-03] Trabecular bone score may manifest as chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotype reciprocal to major cardiovascular outcome Hyojin Yun (Korea)
[OR 01 DL-04] Pre-hemodialysis blood urea nitrogen to creatine ratio for prediction of mortality in hemodialysis patients Ha Yeon Kim (Korea)
[OR 01 DL-05] Cancer incidence and characteristics in the dialysis patients; a Korean nationwide study Soon Kil Kwon (Korea)
[OR 01 DL-06] End stage renal disease and risk of tuberculosis: a nationwide cohort study Yu-Mi Yang (Korea)
[OR 01 DL-07] Factors associated with low trabecular bone scores in patients with end-stage renal disease Da Won Kim (Korea)
[OR 01 DL-08] Impact of Quality-of-Life after Dialysis Start on Survival: A Prospective Cohort Study in Korea Jeonghwan Lee (Korea)
[OR 01 DL-09] Variability of Total Cholesterol is associated with Clinical Outcomes in ESRD patients Minyoung Kim (Korea)
[OR 01 DL-10] Analysis of infection Rate According to Natural Killer Cell Activity in Hemodialysis Patients Seok-hyung Kim (Korea)
[OR 01 DL-11] Effect of Nutritional Status Assessed Using Subjective Global Assessment related to Change of Anemia in Incident Dialysis Patients Tae Hyun Ban (Korea)
[OR 01 DL-12] The combination effect of serum albumin and phosphate levels on all-cause mortality in peritoneal dialysis patients Jong Hyun Jhee (Korea)
Room 3, 4F, Convention Center
Update of IgA Nephropathy  KOR

May 17(Thu), 15:00-17:00

Chair(s)Bum Soon Choi (Korea), Sun-Hee Park (Korea)
[GN 01-01] IgA Nephropathy-diagnosis, prognosis, and outcomes in Korea Seung Hyeok Han (Korea)
[GN 01-02] New insights into the pathogenesis of IgA nephropathy Seung Seok Han (Korea)
[GN 01-03] Current status of steroid-based immunosuppressive therapy for IgA nephropathy Ho Jun Chin (Korea)
[GN 01-04] Novel therapy of IgA nephropathy Jung Eun Lee (Korea)
Room 4, 3F, Convention Center
Overseas Trainee Presentation  KOR

May 17(Thu), 15:00-17:00

Chair(s)Dong Cheol Han (Korea), Nam Ho Kim (Korea)
[OTP-01] The impact of uninephrectomy on acute kidney injury Myung-Gyu Kim (Korea)
[OTP-02] Gene-Edited human kidney organoids reveal mechanisms of disease in podocyte development Yong Kyun Kim (Korea)
[OTP-03] New insight of multiphoton microscopy (MPM) Ju-Young Moon (Korea)
[OTP-04] Efficacy and safety of eculizumab for the treatment of antibody-mediated rejection following renal transplantation Ho Sik Shin (Korea)
[OTP-05] Regenerative medicine and kidney diseases: stem cell-conditioned medium based therapy in renal IRI Hyung Eun Yim (Korea)
Room 1&2, 4F, Convention Center
Opening Ceremony  ENG

May 17(Thu), 17:20-17:30

Opening CeremonySeong Eun Kim (Korea)
Room 1&2, 4F, Convention Center
Plenary Lecture 1  ENG

May 17(Thu), 17:30-18:20

Chair(s)Chun Gyoo Ihm (Korea), Seong Eun Kim (Korea)
[PL 01-01] TonEBP mediates hyperglycemia-induced inflammation, and vascular and renal injury​ Hyug Moo Kwon (Korea)
Room 1, 4F, Convention Center
Pathogenesis of Kidney Disease in Diabetes and Obesity  ENG

May 18(Fri), 08:00-10:00

Chair(s)Jong Soon Lee (USA), Hunjoo Ha (Korea)
[DO 01-01] The role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes Jong Soon Lee (USA)
[DO 01-02] Lipid dysregulation and insulin resistance Jae Bum Kim (Korea)
[DO 01-03] The role of slit-diaphragm associated protein MAGI-2 in progression of CKD Katsuhiko Asanuma (Japan)
[DO 01-04] Adiposity and kidney disease Jung Tak Park (Korea)
Room 2, 4F, Convention Center
Oral Communications (Acute Kidney Injury)  ENG

May 18(Fri), 08:00-10:00

Chair(s)Hye Ryoun Jang (Korea), Myung-Gyu Kim (Korea)
[OR 02 AK-01] Selective digestive decontamination prevents renal ischemic injury and distant organ damage via regulatory T cells expansion Jihyun Yang (Korea)
[OR 02 AK-02] VISTA-dependent role of resident macrophages in kidney homeostasis and inflammation Seung Seok Han (Korea)
[OR 02 AK-03] Construction of mesenchymal stem cells secreting angiogenic or anti-inflammatory factors by ZFN and CRISPR/Cas9 genome-editing technology for the treatment of acute kidney injury Hye-Jeong Park (Korea)
[OR 02 AK-04] Granulocyte-colony stimulating factor ameliorates renal ischemia-reperfusion injury by recruiting myeloid-derived suppressor cells to kidney Ji-Jing Yan (Korea)
[OR 02 AK-05] Longer-interval regimen of colistin reduces nephrotoxicity in kidney-on-a-chip Kipyo Kim (Korea)
[OR 02 AK-06] Major adverse cardiovascular events and clinical outcomes in intensive care unit patients with acute renal replacement therapy Sehoon Park (Korea)
[OR 02 AK-07] Tamoxifen attenuates renal fibrosis through Src kinase in obstructive nephropathy in rats Chang Seong Kim (Korea)
[OR 02 AK-08] Cilastatin preconditioning attenuates oxidative stress and apoptosis through hypoxia inducible factor-1α activation in renal ischemia-reperfusion injury Yu Ah Hong (Korea)
[OR 02 AK-09] Fluid balance after two days of continuous renal replacement therapy initiation is a predictor of 28-day mortality – multicenter cohort study Jung Nam An (Korea)
[OR 02 AK-10] Inhibition of CXCR3 expression through blockade of STAT3 alpha signaling down-regulate inflammation of renal ischemia-reperfusion injury Jae Yoon Park (Korea)
[OR 02 AK-11] Epidemiology of continuous renal replacement therapy in Korea: Results from the national health insurance service claims database from 2005 to 2016 Sehoon Park (Korea)
[OR 02 AK-12] TGF-β1 causes Nox4 dependent hypoxia induced apoptosis in human kidney proximal tubular epithelial cells Se Hee Yoon (Korea)
Room 3, 4F, Convention Center
Hyponatremia, Dyskalemia, and Renal Tubular Acidosis  ENG

May 18(Fri), 08:00-10:00

Chair(s)Shih-Hua Lin (Taiwan), Won Kim (Korea)
[FL 01-01] Management of hyponatremia: from water restriction to tolvaptan Mustafa Arici (Turkey)
[FL 01-02] Differential diagnosis of hypokalemic disorders Shih-Hua Lin (Taiwan)
[FL 01-03] Pathophysiology of hyperkalemia in CKD Susumu Ookawara (Japan)
[FL 01-04] How to approach the patient with endemic renal tubular acidosis in Thailand Somkiat Vasuvattakul (Thailand)
Room 4, 3F, Convention Center
Clinical Significance of Biomarkers in Chilhood Kidney Disease  ENG

May 18(Fri), 08:00-10:00

Chair(s)Kee Hwan Yoo (Korea), Hee Gyung Kang (Korea)
[IK-01] Renal development : from bench to bedside Carlton M. Bates (USA)
[IK-02] Biomarkers of childhood nephrotic & nephritic syndromeWilliam Smoyer (USA)
[IK-03] Biomarkers of congenital ureteral obstruction Kwanjin Park (Korea)
[IK-04] Emerging biomarkers of UTI/VUR in children Hyung Eun Yim (Korea)
Room 3, 4F, Convention Center
Report of Survey Results from Nephrology Fellows in Korea 

May 18(Fri), 10:00-10:30

Report of survey results from nephrology fellows in KoreaTraining and Education Committee
Room 1, 4F, Convention Center
Luncheon Symposium 1 (Sponsored by SK Chemicals, TORAY)  ENG

May 18(Fri), 11:30-12:30

Chair(s)Chun Soo Lim (Korea)
[LS 01-01] Recent progress of uremic pruritus management in Japan Toshiya Ebata (Japan)
Room 2, 4F, Convention Center
Luncheon Symposium 2 (Sponsored by JW Pharmaceutical)  KOR

May 18(Fri), 11:30-12:30

Chair(s)Young Joo Kwon (Korea)
[LS 02-01] Optimal treatment of CKD-MBD targeted at phosphate control Bum Soon Choi (Korea)
Room 3, 4F, Convention Center
Luncheon Symposium 3 (Sponsored by BORYUNG)  KOR

May 18(Fri), 11:30-12:30

Chair(s)Cheol Whee Park (Korea)
[LS 03-01] Update evidence of Kanarb: evaluation the antihypertensive efficacy of fimasartan versus valsartan monotherapy Hajeong Lee (Korea)
[LS 03-02] The outline of the FimAsartaN proTeinuriA SusTaIned reduCtion study (FANTASTIC) in diabetic chronic kidney disease Dong-Ryeol Ryu (Korea)
Room 4, 3F, Convention Center
Luncheon Symposium 4 (Sponsored by Handok Inc.)  ENG

May 18(Fri), 11:30-12:30

Chair(s)Hyeong Cheon Park (Korea)
[LS 04-01] Problems and challenges in the diagnosis and management of aHUS Hermann Haller (Germany)
Room 1&2, 4F, Convention Center
Plenary Lecture 2  ENG

May 18(Fri), 13:00-13:50

Chair(s)Yong-Soo Kim (Korea), Kang Wook Lee (Korea)
[PL 02-01] Cell-based therapy in renal vascular disease: are we there yet? Lilach O Lerman (USA)
Room 1, 4F, Convention Center
APSN-KSN Joint CME Course 1  ENG

May 18(Fri), 14:00-16:00

Chair(s)Hyeong Cheon Park (Korea), Dusit Lumlertgul (Thailand)
[CME-01] Evaluation and care of living kidney donors Hye Eun Yoon (Korea)
[CME-02] Update on management of diabetic nephropathy Masaomi Nangaku (Japan)
[CME-03] Selection of dialysis modality: evidence from cohort studies Jang-Hee Cho (Korea)
[CME-04] The new paradigms in prevention and management of PD-related peritonitis Philip Li (Hong Kong)
Room 1, 4F, Convention Center
APSN-KSN Joint CME Course 2  ENG

May 18(Fri), 16:00-18:00

Chair(s)Masaomi Nangaku (Japan), Yong-Soo Kim (Korea)
[CME-05] Biomarkers of AKI Myung-Gyu Kim (Korea)
[CME-06] IgA nephropathy: 50 years on Sydney Tang (Hong Kong)
[CME-07] Transplantation immunology Sang Ho Lee (Korea)
[CME-08] Drug induced kidney injury Robert Walker (New Zealand)
Room 2, 4F, Convention Center
Oral Communications (Diabetes and Obesity)  ENG

May 18(Fri), 14:00-16:00

Chair(s)Dae Ryong Cha (Korea), Seung Hyeok Han (Korea)
[OR 03 DO-01] The role of PCSK9 on the glomerular lipid accumulation and renal injury in the diabetic kidney disease Mei-yan Wu (China)
[OR 03 DO-02] Glycemic Status and Mortality in Chronic Kidney Disease According to Transition vs. Non-Transition to Dialysis Connie Rhee (United States)
[OR 03 DO-03] Exosomal microRNA signature of obesity using RNA sequencing Haekyung Lee (Korea)
[OR 03 DO-04] The protection effect of diabetic nephropathy by SAR131675 in db/db mice Seon Deok Hwang (Korea)
[OR 03 DO-05] Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy Yong Chul Kim (Korea)
[OR 03 DO-06] Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy So-Young Lee (Korea)
[OR 03 DO-07] Association between weight reduction and developing cardiovascular event among the general population Hae Ryoung Yun (Korea)
[OR 03 DO-08] Poor glycemic control increases mortality in elderly dialysis patients with diabetes - a nationwide prospective cohort in Korea Jung Nam An (Korea)
[OR 03 DO-09] Efficacy and Safety of Metformin in the Patients with Type 2 Diabetic Chronic Kidney Disease Soie Kwon (Korea)
[OR 03 DO-10] Identification of myeloid-derived suppressor cells in type 2 diabetic nephropathy Seung Seok Han (Korea)
[OR 03 DO-11] Bariatric surgery reduces elevated urinary mitochondrial DNA copy number in obese patients Haekyung Lee (Korea)
[OR 03 DO-12] Association between Unintended Weight Loss and Incident Chronic Kidney Disease in People with Metabolic Syndrome: A Community-Based Cohort Study Hae Ryoung Yun (Korea)
Room 3, 4F, Convention Center
Special Session(Hot issue & Future Medicine)  KOR

May 18(Fri), 14:00-16:00

Chair(s)Young Sun Kang (Korea), Joon Ho Song (Korea)
[SPS-01] The forth industrial revolution and future of medicineChiweon Kim (Korea)
[SPS-02] Personal big data for precision medicine: genomes and health recordsJu Han Kim (Korea)
[SPS-03] Application of NGS-based systems biology methods to understand kidney diseases pathogenesis Murim Choi (Korea)
Room 4, 3F, Convention Center
Acute Kidney Injury  ENG

May 18(Fri), 14:00-16:00

Chair(s)Hans-Joachim Anders (Germany), Jaeseok Yang (Korea)
[AKI 02-01] Nuclear receptors in kidney injury: Role of Vitamin D, FXR and PGC-1αSoo Wan Kim (Korea)
[AKI 02-02] Pathophysiology of acute kidney injury - an update Hans-Joachim Anders (Germany)
[AKI 02-03] Macrophages in AKI to CKD transition Sang Kyung Jo (Korea)
[AKI 02-04] Stem cells in acute kidney injury Hoon Young Choi (Korea)
Room 2, 4F, Convention Center
Oral Communications (Renal physiology, Hypertension and Electrolyte disorders)  ENG

May 18(Fri), 16:00-18:00

Chair(s)Soo Wan Kim (Korea), Gheun-Ho Kim (Korea)
[OR 04 RH-01] Long-term administration of empagliflozin contributes to polyuria via transcriptional and post-translational control of aquaporin-2 in diabetic rat kidneys Sungjin Chung (Korea)
[OR 04 RH-02] TAZ is required for the patterning of the juxtamedullay nephron in kidney development Wan-Young Kim (Korea)
[OR 04 RH-03] Histone deacetylase inhibitor, CG200745, attenuates renal fibrosis in DOCA-salt Hypertensive Rats Eun Hui Bae (Korea)
[OR 04 RH-04] Association between Systolic Blood Pressure and Incident Chronic Kidney Disease: A Nationwide Cohort Study Cheol Ho Park (Korea)
[OR 04 RH-05] Metabolic acidosis and clinical outcomes in CKD patients – multicenter large cohort study using instrumental variable analysis Jung Nam An (Korea)
[OR 04 RH-06] Antihypertensive effect of empagliflozin in salt-loaded uninephrectomized rat Sua Kim (Korea)
[OR 04 RH-07] In scilico pharmacological assessment of nifedipine and mibefradil in modulating action potential in guinea pig ureter smooth muscle cells. Chitaranjan Mahapatra (India)
[OR 04 RH-08] Three Cases of Multicentric Carpotarsal Osteolysis Syndrome Peong Gang Park (Korea)
[OR 04 RH-09] Blood pressure control in elderly dialysis patients; a prospective nation-wide ESRD cohort study. Yong Chul Kim (Korea)
[OR 04 RH-10] Tolvaptan use in hyponatremia: short-term observational outcome analysis Ha Yeon Kim (Korea)
[OR 04 RH-11] High variability of initial 24-hour blood pressure is associated with mortality in critically ill patients Kyoung Jin Choi (Korea)
[OR 04 RH-12] Serum levels of sodium and potassium are independently associated with the degree of coronary artery calcification: A single-center cross-sectional study Ki Sung Kim (Korea)
Room 3, 4F, Convention Center
Update of Donor Specific Antibody in KT  KOR

May 18(Fri), 16:00-18:00

Chair(s)Joong Kyung Kim (Korea), Beom Seok Kim (Korea)
[TPL 01-01] DSA detection method & interpretationHyosang Kim (Korea)
[TPL 01-02] Clinical significance of HLA Ab focused on DQ Hye Eun Yoon (Korea)
[TPL 01-03] From antibody to antigen: epitope analysis Eun-Suk Kang (Korea)
[TPL 01-04] How to monitor DSA and what we should do if DSA is present Seungyeup Han (Korea)
Room 4, 3F, Convention Center
Basic Research  ENG

May 18(Fri), 16:00-18:00

Chair(s)Hyug Moo Kwon (Korea), Hunjoo Ha (Korea)
[BR-01] Metabolomics for biomarker discovery in renal transplant rejection Seungil Cho (Korea)
[BR-02] Network-based integrated analysis of transcriptomic and proteomic data reveals novel targets in treatment of peritoneal fibrosis in humans Joo Young Huh (Korea)
[BR-03] Data-driven approaches for efficient drug discovery Wan Kyu Kim (Korea)
[BR-04] A.I. in clinical decision and drug discovery Youngwoo Pae (Korea)
Grand Ballroom, 2F, Main Hotel
KSN Board of Regent 

May 19(Sat), 07:00-08:00

Room 1, 4F, Convention Center
Therapy of Kidney Disease in Diabetes and Obesity  ENG

May 19(Sat), 08:00-10:00

Chair(s)Mitsuo Kato (USA), Eun Young Lee (Korea)
[DO 02-01] MicroRNAs and long noncoding RNAs as therapeutic targets for diabetic nephropathy Mitsuo Kato (USA)
[DO 02-02] Organ crosstalk in diabetic nephropathy Jin Joo Cha (Korea)
[DO 02-03] Modulating inflammation in diabetic nephropathy Ju-Young Moon (Korea)
[DO 02-04] AdiopRon therapy in diabetic nephropathy Yaeni Kim (Korea)
Room 2, 4F, Convention Center
Oral Communications (Dialysis 2)  ENG

May 19(Sat), 08:00-10:00

Chair(s)Kook-Hwan Oh (Korea), Sung Gyun Kim (Korea)
[OR 05 DL-01] Effects of Citrate Versus Acetate Dialysate on Cell Damage, Uremic Toxin, and Inflammation in Patients with Maintenance Hemodialysis Su Woong Jung (Korea)
[OR 05 DL-02] Association of Thyroid Status Prior To Transition to End-Stage Renal Disease with Early Dialysis Mortality Connie Rhee (United States)
[OR 05 DL-03] Impact of dialysate calcium concentration on intradialytic left ventricular systolic function and marker of vascular calcification: A randomized, double-blinded, non-inferiority study (CALLISTO study) Thanawat Vongchaiudomchoke (Thailand)
[OR 05 DL-04] The impact of sunlight exposure on mortality of ESRD patients: a bi-directional case-crossover study in the Korean nation-wide ESRD cohort. Yong Chul Kim (Korea)
[OR 05 DL-05] The impact of hyperuricemia on kidney failure and mortality in a multi-center CKD cohort; an instrumental variable analysis. Yong Chul Kim (Korea)
[OR 05 DL-06] Differential effect of hemoglobin level on patient mortality according to patient age in end stage renal disease patients Eun Jeong Ko (Korea)
[OR 05 DL-07] Intermittent and continuous renal replacement therapy in acute kidney injury: A comparative assessment of cost effectiveness Ambrish Singh (India)
[OR 05 DL-08] The association between neutrophil activation marker and arteriovenous fistula stenosis Hye Min Choi (Korea)
[OR 05 DL-09] GX-E2 versus CERA for Anemia in Patients Receiving Maintenance Peritoneal Dialysis: A Phase 2, Randomized, Multi-center, Active-comparator, Dose-finding, Safety and Efficacy Study Eun Jeong Ko (Korea)
[OR 05 DL-10] The role of suppression of tumorigenicity-2 (ST2) in the peritoneal fibrosis and peritoneal dialysis (PD) outcomes Yong Chul Kim (Korea)
[OR 05 DL-11] Extreme Poverty and CAPD: Challenges and 5 year outcomes from India’s first PPP Peritoneal Dialysis Programme Mayoor Prabhu (India)
[OR 05 DL-12] Bioimpedance-guided fluid management in peritoneal dialysis patients: a randomized controlled trial Hye Eun Yoon (Korea)
Room 3, 4F, Convention Center
Practical Issues of Peritoneal Dialysis  KOR

May 19(Sat), 08:00-10:00

Chair(s)Yong-Lim Kim (Korea), Ki Young Na (Korea)
[PD-01] Management of fluid-overloaded patients Su-Hyun Kim (Korea)
[PD-02] How to manage metabolic complications of PD? Tae Ik Chang (Korea)
[PD-03] Sarcopenic obesity in dialysis patients: PD vs. HD Wonsuk An (Korea)
[PD-04] Management of relapsing or recurrent PD peritonitis Jwa-Kyung Kim (Korea)
Room 4, 3F, Convention Center
CPC  KOR

May 19(Sat), 08:00-10:00

Chair(s)Mee Young Sol, Won Kim, Yeong-Jin Choi, Yu Ah Hong, Kyung Chul Moon, Sang-Youb Han
Case 1
Internal Medicine: Ji-Young Choi
Clinical Discussion: Kum Hyun Han
Pathology: Man-Hoon Han
Case 2
Internal Medicine: Ji Yung Lee
Clinical Discussion: Shin Young Ahn
Pathology: Ji-Youn Sung
Case 3
Internal Medicine: Hyang Kim
Clinical Discussion: Ji Yong Jung
Pathology: Su-Jin Shin
Swan/Crane, 2F, Main Hotel
Meet the Expert  ENG

May 19(Sat), 09:00-10:00

[ME-01] The new therapuetic role of continuous renal replacement therapies (CRRT) in multiple organ dysfunction syndromeClaudio Ronco (Italy)
[ME-02] New insights into AKI to CKD continuum and the role of maladaptive repairMasaomi Nangaku (Japan)
Room 1, 4F, Convention Center
Transplant Infection  ENG

May 19(Sat), 10:00-12:00

Chair(s)Chul Woo Yang (Korea), Yingyos Avihingsanon (Thailand)
[TPL 02-01] Experience of common viral infection in kidney transplant Yingyos Avihingsanon (Thailand)
[TPL 02-02] Detection and management of BK virus in kidney transplantation Ya-Chung Tian (Taiwan)
[TPL 02-03] Prediction of tubuerculosis development after kidney transplantation Jaeseok Yang (Korea)
[TPL 02-04] Risk factors and management of PCP pneumonia Byung Chul Shin (Korea)
Room 2, 4F, Convention Center
Oral Communications (Chronic Kidney Disease 1)  ENG

May 19(Sat), 10:00-12:00

Chair(s)Seung Hyeok Han (Korea), Ki Ryang Na (Korea)
[OR 06 CK-01] Autophagy deficiency in endothelial cells increases the susceptibility of renal injury from aging Yong Kyun Kim (Korea)
[OR 06 CK-02] Autophagy in renal distal tubules attenuates tubulointerstital fibrosis through regulating TGF-β and IL1-β after unilateral ureteral obstruction Yong Kyun Kim (Korea)
[OR 06 CK-03] Transplantation of kidney organoids derived from human iPSCs enhances nephrogenesis Sun Ah Nam (Korea)
[OR 06 CK-04] RNA-seq profiling of microdissected glomeruli in IgA nephropathy patients Sehoon Park (Korea)
[OR 06 CK-05] Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in CKD Jihyun Yang (Korea)
[OR 06 CK-06] cMet agonistic antibody attenuates renal fibrosis in obstructive nephropathy Yong Chul Kim (Korea)
[OR 06 CK-07] Association between the ACTYP2 polymorphisms and risk of IgAN in a Chinese Han population Jiali Wei (China)
[OR 06 CK-08] Newly Designed Recombinant Bone Morphogenetic Protein 7 is a Potential Therapeutic in Renal Tubulointerstitial Fibrosis Seonghun Kim (Korea)
[OR 06 CK-09] COMBINED TREATMENT WITH OMEGA-3 FATTY ACID AND MENAQUINONE-7 ATTENUATES OSTEOPENIA AND SARCOPENIA IN ADENINE AND LOW PROTEIN DIET INDUCED UREMIC RATS Wonsuk An (Korea)
[OR 06 CK-10] Relationship Between Complement Activation and the Oxford Classification Score and Their Combined Effects on Renal Outcome in Early Stage IgA nephropathy Seohyun Park (Korea)
[OR 06 CK-11] Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease Hong Sang Choi (Korea)
[OR 06 CK-12] Role of retinoic acid signaling in chronic kidney disease Jin Joo Cha (Korea)
Room 3, 4F, Convention Center
Update of Glomerulonephritis  ENG

May 19(Sat), 10:00-12:00

Chair(s)Kunitoshi Iseki (Japan), Eun Hui Bae (Korea)
[GN 02-01] Asian perspectives on updated KDIGO GN guideline Kunitoshi Iseki (Japan)
[GN 02-02] Clinical implication of auto-antibodies in membranous nephropathy Sang Ho Lee (Korea)
[GN 02-03] Vasculitis and glomerulonephritis Stephen P. McAdoo (UK)
[GN 02-04] Clinical characteristics of ANCA-negative crescentic GN Sung Woo Lee (Korea)
Room 4, 3F, Convention Center
Renal Pathology  KOR

May 19(Sat), 10:00-12:00

Chair(s)So Young Jin (Korea), Yong-Jin Kim (Korea)
[RP-01] Classification of IgA nephropathy: recent update Ahrim Moon (Korea)
[RP-02] Clinical aspects of IgA nephropathy Hyunwook Kim (Korea)
[RP-03] Classification of lupus nephritis: recent update Beom Jin Lim (Korea)
[RP-04] Clinical aspects of lupus nephritis Hyunwook Kim (Korea)
Room 1, 4F, Convention Center
Luncheon Symposium 5 (Sponsored by FMC Korea)  ENG

May 19(Sat), 12:00-13:00

Chair(s)Kook-Hwan Oh (Korea)
[LS 05-01] Current recommendations for nutritional management of CKD and the role of ketoanalogues Kamyar Kalantar-Zadeh (USA)
Room 2, 4F, Convention Center
Luncheon Symposium 6 (Sponsored by Korea Otsuka Pharmaceutical Co., Ltd.)  ENG

May 19(Sat), 12:00-13:00

Chair(s)Kyu Beck Lee (Korea)
[LS 06-01] Tolvaptan, a novel therapeutic strategy : from evidence into real clinical practice Ken Tsuchiya (Japan)
Room 3, 4F, Convention Center
Luncheon Symposium 7 (Sponsored by Kyowa Hakko Kirin Korea Co., Ltd.)  ENG

May 19(Sat), 12:00-13:00

Chair(s)Yong-Lim Kim (Korea)
[LS 07-01] Expanding roles of calcimimetics in the management of hyperparathyroidism Masafumi Fukagawa (Japan)
Room 4, 3F, Convention Center
Luncheon Symposium 8 (Sponsored by Baxter)  KOR

May 19(Sat), 12:00-13:00

Chair(s)Soo Wan Kim (Korea)
[LS 08-01] Impact of theranova in dialysis patients for nutritional improvement and beyondJai Won Chang (Korea)
Room 4, 3F, Convention Center
General Assembly  KOR

May 19(Sat), 13:00-14:00

Room 1&2, 4F, Convention Center
Plenary Lecture 3  ENG

May 19(Sat), 14:00-14:50

Chair(s)Hyeon Joo Jeong (Korea), Yong-Jin Kim (Korea)
[PL 03-01] Diabetic nephropathy: pathology, pathogenesis, and potential for reversal Charles E. Alpers (USA)
Room 3, 4F, Convention Center
KSN ESRD Registry Report  KOR

May 19(Sat), 14:50-15:10

Chair(s)Seong Eun Kim (Korea)
[ESRD-01] KSN ESRD registry report 2017 Dong-Chan Jin (Korea)
Room 3, 4F, Convention Center
Dialysis Committee  KOR

May 19(Sat), 15:10-16:00

Chair(s)Seong Eun Kim (Korea)
[DC-01] 2018 Report for Hemodialysis Center Accreditation Young-Ki Lee (Korea)
[DC-02] Standards for establishment of hemodialysis units in Korea Seung-Ho Park (Korea)
Grand Ballroom, 2F, Main Hotel
Peer Review and Publication Ethics  KOR

May 19(Sat), 15:00-16:30

Chair(s)Sung-Tae Hong (Korea), Gheun-Ho Kim (Korea)
[KRCP-01] Making peer review more effective Sung-Tae Hong (Korea)
[KRCP-02] How to improve ethics in publication Dong Soo Han (Korea)
Room 4, 3F, Convention Center
Challenges and Advances in Hemodialysis  ENG

May 19(Sat), 15:00-17:00

Chair(s)Kamyar Kalantar-Zadeh (USA), Yong-Soo Kim (Korea)
[HD-01] Expanded HD: mechanisms and clinical outcomes Claudio Ronco (Italy)
[HD-02] Role of super high flux membranes in HDF Ikuto Masakane (Japan)
[HD-03] Benefit of Incremental HD Kamyar Kalantar-Zadeh (USA)
[HD-04] Incremental initiation of hemodialysis: a cohort in Korea Jung Pyo Lee (Korea)
Room 1, 4F, Convention Center
KDIGO-KSN Joint Symposium  ENG

May 19(Sat), 15:30-18:00

Chair(s)Juergen Floege (Germany), Hyeong Cheon Park (Korea)
[JS-01] Treating chronic hepatitis C in patients with chronic kidney disease Jung Il Lee (Korea)
[JS-02] KDIGO guideline update on hepatitis C in CKD: new evidence, new recommendations Michel Jadoul (Belgium)
[JS-03] Arrhythmia and sudden cardiac death in ESRD patients Junbeom Park (Korea)
[JS-04] Heart failure in CKD Andrew House (Canada)
[JS-05] Current status of glomerulonephritis in Korea Ho Jun Chin (Korea)
[JS-06] KDIGO controversies conference on glomerular diseases 2017: a summary Juergen Floege (Germany)
Room 2, 4F, Convention Center
Oral Communications (Transplantation 1)  ENG

May 19(Sat), 16:00-18:00

Chair(s)Sang Ho Lee (Korea), Dong Wan Chae (Korea)
[OR 07 TL-01] Validation study of operational tolerance signature in Korean kidney transplant recipients Yu Ho Lee (Korea)
[OR 07 TL-02] Discovery and validation of urinary mRNA signatures for non-invasive diagnosis of acute rejection Jungwoo Seo (Korea)
[OR 07 TL-03] Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients Kyoung-Woon Kim (Korea)
[OR 07 TL-04] A New risk stratification score for deceased donor kidneys in Korea Tai Yeon Koo (Korea)
[OR 07 TL-05] Effect of Klotho on Autophagy Clearance in Tacrolimus-induced Renal Injury Sun-Woo Lim (Korea)
[OR 07 TL-06] Treatment of chronic hepatitis C infection in renal transplant recipients: Our experience in developing world Sourabh Sharma (India)
[OR 07 TL-07] A multicenter, open-label, randomized, parallel study to evaluate the prevention of New Onset of Diabetes Mellitus after Renal Transplantation following Everolimus therapy with co-administration of low-dose Tacrolimus (PROTECT) Ji-Yeun Chang (Korea)
[OR 07 TL-08] Self in vivo production of a synthetic biological drug, anti-IL-2Rα/IL-10 fusion protein using minicircles in skin allograft model Yoo-Jin Shin (Korea)
[OR 07 TL-09] Effect of Dual Inhibition of Dipeptidyl Peptidase IV (DPP4) and Sodium/glucose Cotransporter (SGLT2) on Tacrolimus-Induced Diabetic Rats Eun Jeong Ko (Korea)
[OR 07 TL-10] Involvement of genetic variation and related gene expression changes on acute rejection in renal transplant recipients Hyeon Seok Hwang (Korea)
[OR 07 TL-11] A Peripheral Blood Transcriptome Analysis and Development of Classification Model for Predicting Antibody-Mediated Rejection versus Accommodation in ABO-incompatible Kidney Transplant Patients Hee Jung Jeon (Korea)
[OR 07 TL-12] Chemokine Receptor 5 Blockade Modulates Macrophage Trafficking in Renal Ischemic Reperfusion Injury Kyung Don Yoo (Korea)
Room 3, 4F, Convention Center
Interim Report of KSN Cooperative Study 

May 19(Sat), 16:00-16:30

Chair(s)Cheol Whee Park (Korea)
Interim Report of KSN Cooperative StudyDong-Ryeol Ryu (Korea)
Interim Report of KSN Cooperative StudyTae-Hyun Yoo (Korea)
Room 3, 4F, Convention Center
Ethics Education  KOR

May 19(Sat), 16:30-18:00

Chair(s)Seung Duk Hwang (Korea), Jong Soo Lee (Korea)
[ETH-01] The apprehesion and current status of medical decision making system for end-stage of life Yoon-seoung Lee (Korea)
[ETH-02] End of life: role of medical personnel Yunsuck Koh (Korea)
[ETH-03] Decision of appropriate initiation and withdrawal from dialysis Seong Eun Kim (Korea)
Room 1, 4F, Convention Center
Aging in Renal Disease  KOR

May 20(Sun), 08:30-10:30

Chair(s)Seung Hwan Sohn (Korea)
[PHY 01-01] Early vascular aging (EVA syndrome) in CKD/ESRD Jung Tak Park (Korea)
[PHY 01-02] Is renal replacement therapy truly beneficial in super-aged patients? Do Hyoung Kim (Korea)
[PHY 01-03] Vascular access for super-aged patientsDan Song (Korea)
Room 2, 4F, Convention Center
Oral Communications (Chronic Kidney Disease 2)  KOR

May 20(Sun), 08:30-10:30

Chair(s)Ho Jun Chin (Korea), Ho Seok Koo (Korea)
[OR 08 CK-01] PGC-1alpha protects TGF-β induced fibrosis by suppressing let7c-mediated TGFβRI expression Hoon-In Choi (Korea)
[OR 08 CK-02] Inhibition of p300/CBP-associated factor attenuates renal tubulointerstitial fibrosis through modulation of NF-kB and Nrf2 Sungjin Chung (Korea)
[OR 08 CK-03] A clinical significance of crescent formation in IgA nephropathy Sehoon Park (Korea)
[OR 08 CK-04] Urinary myo-inositol as a potential marker for focal segmental glomerulosclerosis: NMR-based metabolomics study Jung Nam An (Korea)
[OR 08 CK-05] Effect of pentoxifylline on pericyte in aging mice kidney Hyung Duk Kim (Korea)
[OR 08 CK-06] Higher muscle to fat ratio is associated with lower CKD development risk in subjects with normal renal function: Community based prospective cohort study Jong Hyun Jhee (Korea)
[OR 08 CK-07] Effect of statin on cardiovascular complications in chronic kidney disease patients: A Network Meta-Analysis Seon Deok Hwang (Korea)
[OR 08 CK-08] The role of periostin in aging process Young Wook Choi (Korea)
[OR 08 CK-09] Protective effect of DNA methyltrasferase inhibitor against progressive renal tubulointerstitial inflammation and fibrosis Eun Sil Koh (Korea)
[OR 08 CK-10] The role of fumarate in the progression of membranous nephropathy: metabolomics analysis and its in-vitro validation. Hyung Ah Jo (Korea)
[OR 08 CK-11] Knockdown of Peroxiredoxin V (Prdx V) exacerbates unilateral ureteral obstruction-induced renal fibrosis Hoon-In Choi (Korea)
[OR 08 CK-12] The effects of high salt or high fat diet on murine intrarenal immunologic micromilieu Junseok Jeon (Korea)
Room 3, 4F, Convention Center
Dialysis Nurse Course 1  KOR

May 20(Sun), 08:30-10:30

Chair(s)Chang Suk Lee (Korea)
[NUR 01-01] Infection control Jin-hee Han (Korea)
[NUR 01-02] Disaster preparedness: for medical assistance Han Joo Choi (Korea)
[NUR 01-03] A comparative study of citrate-enriched bicarbonate based dialysate on blood pressure and heparin requirements and hemodialysis adequacy in maintenance hemodialysis patients Young Ok Choi (Korea)
Room 4, 3F, Convention Center
Common Issues Confronting During Online Hemodiafiltration  KOR

May 20(Sun), 08:30-10:30

Chair(s)Sug Kyun Shin (Korea), Young-il Jo (Korea)
[HDF-01] Mode of HDF – which is good: pre- or post-dilution? Kyubok Jin (Korea)
[HDF-02] Dose of HDF – how to achieve high convection volume Young-Ki Lee (Korea)
[HDF-03] Complications during online HDFJai Won Chang (Korea)
[HDF-04] Cost - medical reimbursement Yang Wook Kim (Korea)
Grand Ballroom, 2F, Main Hotel
Hands-on Session 

May 20(Sun), 08:30-10:40

[Hand-01] Basic setting for vascular access ultrasonographyHoon Suk Park (Korea)
Hands-on
Clinical anatomy for vascular access
Basic setting for vascular access ultrasonography
Flow rate assessment of brachial artery
Room 1, 4F, Convention Center
Blood Pressure in CKD/ESRD Patients  KOR

May 20(Sun), 11:00-12:30

Chair(s)Yoon Chul Jung (Korea)
[PHY 02-01] Hypertension in CKD/ESRD; Korean perspectives Ran-hui Cha (Korea)
[PHY 02-02] Blood pressure variability and its impact on CKD/ESRD patientsJung Pyo Lee (Korea)
[PHY 02-03] Antihypertensive medication use in the transition from CKD to dialysis Jung Eun Lee (Korea)
Room 2, 4F, Convention Center
Oral Communications (Transplantation 2)  KOR

May 20(Sun), 11:00-13:00

Chair(s)Suk Young Kim (Korea), Chan-Duck Kim (Korea)
[OR 09 TL-01] Impact of Serum Vitamin D Status on Vascular Calcification after Kidney Transplantation Jung Hwa Ryu (Korea)
[OR 09 TL-02] Impact of acute kidney injury in elderly deceased donor on the post-transplant clinical outcomes: Multicenter cohort study Jeong Ho Kim (Korea)
[OR 09 TL-03] Characteristics of Recipients Who Discontinued Antihypertensive Medication within 1-Year after Kidney Transplantation: Results from the KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) Study SEONG SIK KANG (Korea)
[OR 09 TL-04] Long term risks for kidney donors: ESRD and mortality Yaerim Kim (Korea)
[OR 09 TL-05] Differentiation Efficiency of Human Induced Pluripotent Stem Cell (iPSC) to Endothelial Cells in Patients with End Stage Renal Disease (ESRD) Eun Jeong Ko (Korea)
[OR 09 TL-06] Clinical Experience of Latent Tuberculosis Infection in Living Donor Kidney Transplant Recipients Tae Hyun Ban (Korea)
[OR 09 TL-07] Impact of ABO incompatible kidney transplantation on retransplantation Hyung Duk Kim (Korea)
[OR 09 TL-08] Targeting class I histone deacetylase in renal tubular epithelial cells inhibits priming inflammatory responses Sun Woo Kang (Korea)
[OR 09 TL-09] Low Pre-transplant Intact Parathyroid Hormone Is A Risk Factor for Bone Loss after Kidney Transplantation Seohyun Park (Korea)
[OR 09 TL-10] The potential role of IL-33/ST2 in renal allograft rejection Mi Yeon Yu (Korea)
[OR 09 TL-11] The risk factors of persistent hyperparathyroidism in children who received kidney transplantation. Joo Hoon Lee (Korea)
[OR 09 TL-12] Comparison of the impact of Kidney Donor Profile Index on the Post-Transplant Clinical Outcomes between Elderly and Young Kidney Transplant Recipients; Multicenter Cohort Study Woo Yeong Park (Korea)
Room 3, 4F, Convention Center
Dialysis Nurse Course 2  KOR

May 20(Sun), 11:00-13:00

Chair(s)Sang-Youb Han (Korea), Young-Ki Lee (Korea)
[NUR 02-01] Dialysis for the aging populations Ji Eun Lee (Korea)
[NUR 02-02] Management of hyperkalemia in dialysis patients: what is on the horizon? Young Youl Hyun (Korea)
[NUR 02-03] Update on uremic toxins: concepts and novelties So Young Lee (Korea)
Room 4, 3F, Convention Center
Serum Electrolytes as Predictors for Clinical Outcomes  KOR

May 20(Sun), 11:00-13:00

Chair(s)Gheun-Ho Kim (Korea), Kyung Hwan Jeong (Korea)
[FL 02-01] Prognostic significance of hyponatremia in dialysis patients Tae Ik Chang (Korea)
[FL 02-02] Outcomes in hospitalized patients with dyskalemia Sejoong Kim (Korea)
[FL 02-03] Optimal serum bicarbonate levels in CKD patients Eun Hui Bae (Korea)
Grand Ballroom, 2F, Main Hotel
Hands-on Session 

May 20(Sun), 11:10-13:20

[Hand-02] US surveillance for vascular accessSun Ryung Choi (Korea)
Hands-on
Surveillance for vascular access
Detection of problems in vascular access
Establishment of therapeutic strategy